REDWOOD CITY, Calif. -- GenapSys (Genapsys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Priya Ray and Peter Swider to the Company's leadership team as well as the launch of the company's new branding and corporate website, www.genapsys.com. "We are pleased to welcome Priya and Peter to our accomplished and growing leadership team," said Jason Meyers, [...]

Veranome’s Spatial Analyzer (VSA-1) is a fully automated spatial transcriptomics system for reliable, high throughput cyclic FISH assays. Available now, Veranome’s Spatial Analyzer, Model VSA-1, is the first and only system adapting proven semiconductor process control technology to ensure the highest quality data with throughput configurable for both individual and core lab operations. New product [...]

REDWOOD CITY, Calif. — Genapsys, Inc. (Genapsys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Priya Ray and Peter Swider to the Company’s leadership team as well as the launch of the company’s new branding and corporate website, www.genapsys.com. “We are pleased to welcome Priya and Peter [...]

SANTA FE, N.M., USA, & KYIV, Ukraine – OpenEye Scientific and Enamine, a leading global provider of billions of new screening compounds to the drug discovery market, are partnering to enable faster and more accurate virtual screening of ultra-large compound libraries through access to innovative software. Using Orion®, OpenEye’s cloud-native molecular design platform, scientists can: [...]

BOSTON -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, and Scripps Research have been awarded a $7.5M contract to develop a federated data ecosystem for the National Institute of Allergy and Infectious Diseases (NIAID) under a project titled the NIAID Data Ecosystem (NDE). The NDE will be a secure environment to find, access, query and analyze data from select NIAID repositories, [...]

Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions, announced today the completion of a $24M financing from new and existing investors. The funding will drive the commercialization and applications for the Company’s new Orion spatial biology platform and further global expansion [...]

Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. Sustain and secure the supply chain for customers in China and the broader region.  With the use of Fortem™ film, Cytiva helps customers speed up their clinical manufacturing and product launches; improve manufacturing [...]

– Research collaboration covers multiple antibody research programs – SOUTH SAN FRANCISCO, Calif. & INGELHEIM, Germany -- Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries [...]

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) elevates climate action goals with commitments for net zero greenhouse gas emissions aligned with the Paris Agreement, commits to verified Science Based Targets, signs the Business Ambition for 1.5 degree and joins the United Nations campaign Race to Zero. "Human health and the health of our environment are intertwined. At Illumina, [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH (“Navigo”), today announced they have completed development and validation of a novel protein A ligand that overcomes challenges associated with the purification of pH sensitive antibodies and Fc-fusion proteins. Named NGL-Impact® A Hi pH, the new ligand [...]